FORTE BIOSCIENCES FBRX 深 沪
已收盘 05-22 16:00:00 美东时间
21.59
-0.410
-1.86%
华盛通- 最 高22.35
- 今 开21.79
- 成交量 12.40万股
- 最 低 20.69
- 昨 收 22.00
- 总市值 4.42亿
- 52周最高 35.7999
- 市盈率 静 --
- 换手率 0.61%
- 52周最低 7.78
- 委 比 -96.52%
- 总股本 2047.88万
- 历史最高 6732.375
- 量 比 0.51
- 振 幅 7.55%
- 历史最低 4.90
- 每 手 1
- 风险率 8.20%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Forte Biosciences Q1 EPS $(1.24) Misses $(1.19) Estimate
Forte Biosciences (NASDAQ:FBRX) reported quarterly losses of $(1.24) per share which missed the analyst consensus estimate of $(1.19) by 4.2 percent. This is a 9.49 percent increase over losses of $(1.37) per share from
05-11 21:06
美股牛股 | ZNTL飙升60%，卵巢癌临床试验获重大突破；IVVD大涨31%
ZNTL飙升60%，卵巢癌临床试验获重大突破；IVVD大涨31%，就儿科临床研究与FDA达成一致；EOSE大涨近30%，Q1财报强劲，营收创新高>>
04-10 19:22
Forte Biosciences shares are trading lower after the company announced a proposed public offering.
Forte Biosciences shares are trading lower after the company announced a propos...
04-09 04:18
Forte Biosciences Reveals Proposed Public Offering; No Size Disclosed
Forte Biosciences, Inc. (NASDAQ:FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced that it has commenced an underwritten public offering of shares of
04-09 04:03
Forte Biosciences Q4 EPS $(1.45) Misses $(1.06) Estimate
Forte Biosciences (NASDAQ:FBRX) reported quarterly losses of $(1.45) per share which missed the analyst consensus estimate of $(1.06) by 37.05 percent. This is a 22.88 percent decrease over losses of $(1.18) per share
04-01 05:21
美股牛股 | 存储再度狂飙！Sandisk大涨逾15%；生物技术公司TWST涨约14%，Q1业绩超预期
存储再度狂飙！Sandisk大涨逾15%，伯恩斯坦上调目标价至1000美元；生物技术公司TWST涨约14%，Q1业绩超预期；欧朋涨超13%，此前上调Q4收入预期指引>>
02-03 15:29
美股牛股 | 私人航空公司UP单日暴涨46%！One Stop大涨29%，获美军预生产订单
私人航空公司UP单日暴涨46%！One Stop股价涨29%，获美军预生产订单；BIOA涨逾27%，核心在研药获突破进展>>
01-13 17:24
美股大行评级 | 安捷伦科技、Keysight、先科电子获多家大行上调目标价；摩根大通下调亿航智能评级至"中性"，目标价下调至13美元
今日重点评级关注：HC Wainwright & Co.：维持BiomX"买入"评级，目标价从15美元升至26美元；Clear Street：维持Diversified Energy"买入"评级，目标价从23美元升至25美元
2025-11-26 10:07
Evercore ISI Group Initiates Coverage On Forte Biosciences with Outperform Rating, Announces Price Target of $65
Evercore ISI Group analyst Gavin Clark-Gartner initiates coverage on Forte Biosciences (NASDAQ:FBRX) with a Outperform rating and announces Price Target of $65.
2025-11-25 20:56
美股大行评级 | Stifel上调特斯拉目标价升至508美元；多家大行上调Vita Coco目标价最高至58美元
今日重点评级关注：HC Wainwright & Co.：维持Oncolytics Biotech"买入"评级，目标价从5美元升至10美元；HC Wainwright & Co.：维持Barinthus Biotherapeutics"买入"评级，目标价从3美元升至4美元
2025-11-18 15:28
